Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Immunohorizons|October 20, 2019
DPI Selectively Inhibits Intracellular NADPH Oxidase Activity in Human NeutrophilsAlicia Buck, Felix P Sanchez Klose, Vignesh Venkatakrishnan, et al.
International Journal of Molecular Sciences|May 30, 2020
In Vivo Transmigrated Human Neutrophils Are Highly Primed for Intracellular Radical Production Induced by Monosodium Urate CrystalsLisa Davidsson, Agnes Dahlstrand Rudin, Felix Peter Sanchez Klose, et al.
Prehospital and Disaster Medicine|May 19, 2022
Medication-Facilitated Advanced Airway Management with First-Line Use of a Supraglottic Device - A One-Year Quality Assurance ReviewBethany J Johnston, Alison K Leung, Charles W Hwang, et al.
Cancer Letters|July 19, 2017
Sensitivity towards the GRP78 inhibitor KP1339/IT-139 is characterized by apoptosis induction via caspase 8 upon disruption of ER homeostasisBeatrix Schoenhacker-Alte, Thomas Mohr, Christine Pirker, et al.
Cell Reports. Medicine|January 31, 2025
CAR T cells, CAR NK cells, and CAR macrophages exhibit distinct traits in glioma models but are similarly enhanced when combined with cytokinesThomas Look, Roman Sankowski, Manon Bouzereau, et al.
Science Translational Medicine|July 19, 2023
Targeting the Siglec-sialic acid axis promotes antitumor immune responses in preclinical models of glioblastomaPhilip Schmassmann, Julien Roux, Alicia Buck, et al.
Molecular Therapy Oncolytics|February 4, 2022
Anti-CAIX BBζ CAR4/8 T cells exhibit superior efficacy in a ccRCC mouse modelYufei Wang, Alicia Buck, Marion Grimaud, et al.
Iscience|February 8, 2024
Immune-restoring CAR-T cells display antitumor activity and reverse immunosuppressive TME in a humanized ccRCC mouse modelYufei Wang, Jae-Won Cho, Gabriella Kastrunes, et al.
Nature Communications|November 9, 2024
Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blockerTomás A Martins, Deniz Kaymak, Nazanin Tatari, et al.
Science Translational Medicine|June 18, 2025
Adoptive cell therapy with macrophage-drug conjugates facilitates cytotoxic drug transfer and immune activation in glioblastoma modelsMiaomiao Sun, Maciej Bialasek, Maud Mayoux, et al.
Pageof 2